Obesity
📧 Sign up to get email alerts when something new happens for Obesity.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-02-27Clinical Trial Update: Metabolic Flexibility and Metabolic Heath in Human Obesity [NA]
Clinical trial update for a study on metabolic flexibility and metabolic health in obesity led by Jose Galgani. The trial status is complete…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: A Study Comparing the Efficacy and Safety of HRS9531 Injection With Semaglutide Injection in Subjects With Obesity [Phase 3]
A Phase 3 clinical trial compares HRS9531 injection with semaglutide in adults with obesity; the study is currently active but not recruitin…
-
CLINICAL_TRIALS trial_result · 2026-02-27Clinical Trial Update: Impact Of Laparoscopic Sleeve Gastrectomy On Obesity-Related Comorbidities In Patients Over 65 Years [NA]
Completed clinical trial from Kafrelsheikh University assessing the impact of laparoscopic sleeve gastrectomy on obesity-related comorbiditi…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Sympathetic Mechanisms in Obesity-Crossover Design [Phase 1, Phase 2]
Vanderbilt University Medical Center is conducting a Phase 1/2 crossover trial exploring sympathetic mechanisms in obesity. The study target…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: A Study of MET233 in Individuals With Obesity or Overweight [Phase 1, Phase 2]
A clinical trial update for MET233 in adults with obesity or overweight, spanning Phase 1 and Phase 2, sponsored by Metsera (a Pfizer subsid…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: A Study to See How Safe a New Medicine (NNC6989-0001) is in Healthy People Living With Overweight or Obesity [Phase 1]
Phase 1 safety trial of NNC6989-0001 is currently recruiting in adults with overweight or obesity. The study is sponsored by Novo Nordisk A/…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: NUTRIMOOD-Inflammation and Depressive Comorbidity in Obesity: Modulation by Omega-3 Polyunsaturated Fatty Acids Status [NA]
This clinical trial in Taiwan investigates whether omega-3 fatty acid status modulates inflammation and depressive symptoms in obesity among…
-
CLINICAL_TRIALS trial_result · 2026-02-27Clinical Trial Update: Cardiometabolic Risk Factor Management and Adherence to Antihypertensive Therapy in Patients With Severe Obesity Prior to Bariatric Surgery: a Prospective Longitudinal Cohort Study
This ClinicalTrials.gov update notes the completion of a prospective longitudinal cohort study evaluating cardiometabolic risk factor manage…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Reducing Weight and Elevated Stress Levels Using Educational and Behavioral Tools [NA]
This entry summarizes an ongoing clinical trial focused on reducing weight and elevated stress in obesity using educational and behavioral t…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Effect of Electroacupuncture on Central Obesity and Fatty Liver in Postmenopausal Women [NA]
This clinical trial is evaluating whether electroacupuncture can reduce central obesity and fatty liver in postmenopausal women, and it is n…
-
EMA approval · 2026-02-26EMA Authorised: Mounjaro (tirzepatide) — Eli Lilly Nederland B.V.
The EMA authorised Mounjaro (tirzepatide) for adults with type 2 diabetes and for obesity/overweight, granting EU marketing authorisation to…
-
FDA approval · 2026-02-25FDA Approved: SAXENDA — Supplemental Application (Novo Nordisk)
FDA approved a supplemental application for SAXENDA (liraglutide) submitted by Novo Nordisk.
-
FDA approval · 2026-02-25FDA Approved: WEGOVY — Supplemental Application (Novo Nordisk)
The FDA approved Novo Nordisk's supplemental application for Wegovy (semaglutide), updating the approval to support its chronic weight-manag…
-
FDA approval · 2026-02-25FDA Approved: WEGOVY — Supplemental Application (Novo Nordisk)
FDA approved a supplemental application for Wegovy (semaglutide) from Novo Nordisk. The approval pertains to changes to the product labeling…
-
CLINICAL_TRIALS trial_result · 2026-02-25Clinical Trial Update: Research Study Looking at How Well Semaglutide Tablets Taken Once Daily Work in People Who Have a Body Weight Above the Healthy Range [Phase 3]
A Phase 3 study evaluating daily oral semaglutide tablets for individuals with overweight or obesity has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2026-02-25Clinical Trial Update: A Study of Orforglipron (LY3502970) in Adult Participants With Obesity or Overweight [Phase 1]
Phase 1 trial evaluating Orforglipron (LY3502970) in adults with obesity or overweight has completed; the update likely reports safety, tole…
-
CLINICAL_TRIALS trial_result · 2026-02-25Clinical Trial Update: Effect of Erector Spinae Plane Block on Postoperative Analgesia and Stress Response in Laparoscopic Sleeve Gastrectomy [NA]
A completed clinical trial evaluated the effect of an erector spinae plane block on postoperative analgesia and stress response in patients …
-
CLINICAL_TRIALS trial_result · 2026-02-25Clinical Trial Update: Effect of Gabapentin on Kidney Function Following Laparoscopic Sleeve Gastrectomy(LSG) [Phase 4]
A Phase 4 clinical trial assessing the effect of gabapentin on kidney function in obese patients undergoing laparoscopic sleeve gastrectomy …
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: A Single Ascending Dose Study of HM17321 in Healthy Adult Participants [Phase 1]
A Phase 1 single ascending dose study of HM17321 in healthy adults, evaluating safety and pharmacokinetics in the context of obesity-related…
-
CLINICAL_TRIALS trial_result · 2026-02-25Clinical Trial Update: Probiotics in Alleviating Microplastic-Induced Obesity [NA]
A completed clinical trial from Fudan University evaluating whether probiotics can alleviate microplastic-induced obesity, with intestinal f…
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: A Research Study to Compare Different Versions of Injectable CagriSema and Placebo in People With Excess Body Weight [Phase 3]
This is a Phase 3 trial sponsored by Novo Nordisk to compare injectable CagriSema with placebo in adults with overweight or obesity; recruit…
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: Impact of Supplementation in Improving Metabolic Health Outcomes (ISMOS) Study [NA]
An ongoing Singapore-based clinical trial (ISMOS) is evaluating whether a nutritional supplement can improve metabolic health outcomes, incl…
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: GLP-1 RA on Alcohol Consumption, Metabolism and Liver Parameters in Patients With Obesity and Fatty Liver Disease [NA]
A clinical trial is evaluating a GLP-1 receptor agonist for effects on alcohol consumption, metabolism, and liver parameters in patients wit…
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: Advancing Biopsychosocial Care Training Initiative [NA]
Clinical trial update for Advancing Biopsychosocial Care Training Initiative at Washington University School of Medicine; the study targets …
-
CLINICAL_TRIALS withdrawal · 2026-02-25Clinical Trial Update: A Ph2 Study to Evaluate the Safety, Efficacy and Tolerability of HT-6184 and Semaglutide in Obese Participants With T2DM [Phase 2]
Phase 2 study evaluating HT-6184 in combination with semaglutide for obese participants with type 2 diabetes has been withdrawn.